There are well-recognized sex differences in many pituitary endocrine axes, usually thought to be generated by gonadal steroid imprinting of the neuroendocrine hypothalamus. However, the recognition that growth hormone (GH) cells are arranged in functionally organized networks raises the possibility that the responses of the network are different in males and females. We studied this by directly monitoring the calcium responses to an identical GH-releasing hormone (GHRH) stimulus in populations of individual GH cells in slices taken from male and female murine GH-eGFP pituitary glands. We found that the GH cell network responses are sexually dimorphic, with a higher proportion of responding cells in males than in females, correlated with greater GH release from male slices. Repetitive waves of calcium spiking activity were triggered by GHRH in some males, but were never observed in females. This was not due to a permanent difference in the network architecture between male and female mice; rather, the sex difference in the proportions of GH cells responding to GHRH were switched by postpubertal gonadectomy and reversed with hormone replacements, suggesting that the network responses are dynamically regulated in adulthood by gonadal steroids. Thus, the pituitary gland contributes to the sexually dimorphic patterns of GH secretion that play an important role in differences in growth and metabolism between the sexes. sex hormones | body growth | calcium signaling | systems biology I n most species, males and females display a marked phenotypic divergence in body size, with increased growth rate and body mass being a predominantly masculine trait. Furthermore, in all species examined to date, the growth hormone (GH) axis demonstrates sex-specific differences in hormone contents, secretory outputs, and secretory patterns (1) and their effects on gene expression (2-4). The secretion of GH is controlled by hypothalamic GH-releasing hormone (GHRH) and somatostatin, and there is good evidence for sex-specific imprinting on hypothalamic hypophysiotropic neurons exerted by gonadal steroid exposure early in life (5), with ongoing effects during puberty (6). This has led to the conclusion that the sexually dimorphic control of GH patterns reflects sex differences in GHRH and somatostatin inputs to the pituitary gland. Acute changes in gonadal steroid environment drastically alter the patterns of GH pulsatility in adulthood (7,8); however, although they receive sexually dimorphic inputs (9, 10), GHRH neurons do not display sex-specific electrical characteristics (9, 11). We have previously shown that GH cells in the male mouse pituitary gland form an extensive homotypic cell network with an architecture that exhibits marked plasticity during sexual maturation and that can be altered by gonadectomy (12). Thus, it was important to determine whether male and female pituitary glands would show different responses to the same stimulus in the absence of any hypothalamic influence. To explore this, we assessed the functional activit...

Although growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas are considered benign, in many patients, tumour growth and/or invasion constitute a particular challenge. In other tumours, progression relies in part on dysfunction of intercellular adhesion mediated by the large family of cadherins. In the present study, we have explored the contribution of cadherins in GH and PRL adenoma pathogenesis, and evaluated whether this class of adherence molecules was related to tumour invasiveness. We have first established, by quantitative polymerase chain reaction and immunohistochemistry, the expression profile of classical cadherins in the normal human pituitary gland. We show that the cadherin repertoire is restricted and cell-type specific. Somatotrophs and lactotrophs express mainly E-cadherin and cadherin 18, whereas N-cadherin is present in the other endocrine cell types. This repertoire undergoes major differential modification in GH and PRL tumours: E-cadherin is significantly reduced in invasive GH adenomas, and this loss is associated with a cytoplasmic relocalisation of cadherin 18 and catenins. In invasive prolactinomas, E-cadherin distribution is altered and is accompanied by a mislocalisation of cadherin 18, β-catenin and p120 catenin. Strikingly, de novo expression of N-cadherin is present in a subset of adenomas and cells exhibit a mesenchymal phenotype exclusively in invasive tumours. Binary tree analysis, performed by combining the cadherin repertoire with the expression of a subset of known molecular markers, shows that cadherin/catenin complexes play a significant role in discrimination of tumour invasion.